Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2019

Open Access 01.12.2019 | Case report

Infratentorial immature teratoma of congenital origin can be associated with a 20-year survival outcome: a case report and review of literature

verfasst von: Yazid Maghrabi, Maher E. Kurdi, Saleh S. Baeesa

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2019

Abstract

Background

Congenital intracranial tumors are very rare and account for less than 2% of all childhood brain tumors. Teratomas constitute about one third to one half of these, predominantly located midline in the supratentorial region. Posterior fossa location rarely occurs and, based on the cases reported in the literature, commonly has a poor prognosis.

Case presentation

A newborn female, diagnosed prenatally with hydrocephalus, is presented at birth with increasing head circumference and Parinaud’s syndrome. Magnetic resonance imaging scans demonstrated a huge posterior fossa tumor with obstructive hydrocephalus. At surgery, through a suboccipital craniotomy, complete excision was achieved of a histological-proven immature teratoma. The infant received adjuvant chemotherapy for 1 year. She had normal neurological development and remained tumor-free through her 20-year follow-up.

Conclusion

The authors report this rare case of congenital posterior fossa teratoma with long-term outcome, and the literature is reviewed.
Abkürzungen
CARE
Carboplatin and etoposide

Background

Congenital intracranial tumors are a rare occurrence, accounting for only 0.5–1.5% of all childhood brain tumors [1]. The most common of these tumors are teratomas, which comprise between 28.8 and 50.0% of central nervous system tumors [2, 3]. Teratomas are considered to be a subtype of germ cell tumors, containing all types of embryonic germ cell layers (ectoderm, mesoderm, and endoderm) [4]. Commonly, they are located in the supratentorial region, and in Wakai et al.’s review of 200 cases, only one was found in the posterior fossa [5]. Thus, infratentorial teratomas are rare entities. Histopathologically, teratomas are categorized as mature or immature [6]. Immature teratomas are associated with poor prognosis, due to the malignant behavior and presentation at a young age [6].
The Authors report this rare case of a posterior fossa congenital teratoma presented with Parinaud’s syndrome with long-term survival and review the literature.

Case report

A newborn female of an uneventful pregnancy of a 40-year-old woman was delivered on 1 January 1999 via cesarean section (CS) at full term, because of previous CS. She is the sixth child of non-consanguineous Saudi Arabian parents who were originally from Gizan. During her gestational period, routine fetal ultrasonographic (US) scans at the 34th week reported mild ventriculomegaly without mention of any associated brain tumor.
At birth, her Apgar score was 8 and 10, and her weight was 3150 g. Her head circumference after birth was in the 90th percentile, and the anterior fontanel was 20 × 20 mm and soft. The initial neurological exam was normal, apart from a squint, and her parents were reassured.
At the age of 3 days, her mother brought her to a polyclinic because of poor feeding. She was reassured, and a change of milk formula was satisfactory for 1 week. Because of her recurrent vomiting and irritability, a computed tomography (CT) scan was performed, which reported a large posterior fossa tumor with obstructive hydrocephalus.
On admission at 20 days old to King Abdulaziz University Hospital in Jeddah, she presented with frequent vomiting, poor feeding, and increasing head circumference. The general physical exam revealed an irritable and emaciated baby in the second percentile of weight for her age. Head circumference was 45 cm with visibly dilated scalp veins and bulging anterior fontanel. Neurological exam demonstrated a conscious baby with spontaneous movement of her upper and lower extremities with mild spasticity. Cranial nerves exam was uneventful apart from Parinaud’s syndrome (Fig. 1). Pupillary reflex was sluggish to light and vision was normal with no papilledema detected. Routine laboratory screening tests were within normal limits. Magnetic resonance imaging (MRI) scans revealed a heterogeneous 60 × 55 × 45 mm midline tumor filling most of the posterior fossa, causing anterior displacement of the brain stem and marked obstructive hydrocephalus (Fig. 2). The tumor was iso- to hyperintense on T1-weighted images and hypointense on T2-weighted images with heterogeneous enhancement.
Through a midline suboccipital craniotomy, complete resection of the tumor was achieved. During surgery, an encapsulated solid vascular tumor occupying the fourth ventricle was encountered with diverse areas of soft and firm consistency. The baby remained stable hemodynamically throughout the surgery and received a total of 250 ccs packed RBC blood. During the operation, cerebrospinal fluid (CSF) was obtained for analysis, which was within normal limits for chemistry and cell counts. CSF cytology and tumor markers studies, human chorionic gonadotropin, and alpha-fetoprotein were negative. Histopathological examination of the specimen demonstrated a variety of tissues from all three germ layers, including immature as well as mature elements. The predominant tissue was neuroectodermal, in the form of neuroepithelial rosettes and tubules, resembling neuroblastoma. Mesodermally derived immature cartilage and primitive stroma were also seen, and endodermally derived respiratory and enteric epithelium was present in the form of cystic structures (Fig. 3). The diagnosis was consistent with immature teratoma. During the postoperative period, the baby developed pneumonia that was resolved with intravenous antibiotics, and early postoperative MRI scans confirmed complete resection. She was discharged home on the 15th postoperative day in good condition. The infant received and well tolerated adjuvant carboplatin and etoposide (CARE) chemotherapy.
At the first year anniversary follow-up, she had a mild developmental delay with a slight improvement of Parinaud’s syndrome. Follow-up MRI scans at the fifth year of age revealed the stable size of the ventricles with no tumor recurrence (Fig. 4). The patient was followed annually and had normal cognitive and neurological development; she is a university student and her recent CT scan at the age of 20 years revealed no recurrence (Fig. 5).

Discussion

Primary brain tumors form 20% of pediatric neoplasms and are the second most prevalent cancer of childhood, after leukemia [7]. Teratomas, although tumors of gonads, also arise from the central nervous system [8]. Extragonadal teratomas are congenital midline tumors, located both intracranially and extracranially, e.g., in the mediastinum and retroperitoneal area [8]. They are considered to originate from primordial germ cells that fail to migrate properly during the initial weeks of embryonic development [8].
The incidence of intracranial teratoma is 0.5% of all brain tumors and 2 to 4% of intracranial tumors in the pediatric age group [911]. This becomes statistically more significant for intracranial tumors presenting at or around birth. Congenital teratomas are the most frequent intracranial tumor of the perinatal and neonatal period and are five times more common than astrocytomas, which are next in frequency at this age [3]. That is why they are considered as the leading prenatal neoplasms, according to multiple reviews [3]. Considering tumors in the pediatric age group, male children are affected more than female children, but in neonates, females predominate [9]. Both supra- and infratentorial tumors have been reported with the majority being supratentorial, contrary to the usual pattern of brain tumors observed in the pediatric age group [12].
Common presenting symptoms and signs of such tumors include symptoms related to the outflow obstruction of cerebrospinal fluid resulting in a headache, vomiting, and papilledema (Table 1) [4, 13]. Moreover, the progressive increase in head size has also been observed in many reported cases including our current case (Table 1) [4, 1316]. Infants with teratoma present with seizures in around 20% of cases [4, 13]. Compression of the tectal plate can result in what is known as Parinaud’s syndrome, which is characterized by vertical gaze palsy, convergence palsy, and accommodation palsy [14]. The tectal plate can be compressed through several mechanisms including hydrocephalus, causing either (a) direct compression of the tectal plate of the midbrain by the distended ventricular system or (b) secondary herniation, with resultant brainstem ischemia or neuronal distortion.
Table 1
Review of reported congenial teratoma cases confined to the posterior fossa
Author (year)
Mode of delivery and Apgar score
Age at diagnosis
Signs and symptoms
Tumor size
Tumor location
Histopathology
Neurosurgical intervention
Outcome
Follow-up
Current case
C section, 8 at 1 min, 10 at 5 min
20 days
Vomiting, poor feeding, and increasing head circumference
6 × 5.5 × 4.5 cm
Posterior fossa
Immature teratoma
Total resection
Alive
20 years
Algahtani et al. (2018) [22]
SVD, NR
5 years
Headache, vomiting, and irritability
NR
Posterior fossa
Mature teratoma
Total resection
Alive
6 years
Daugherty et al. (2016) [23]
NR
15 years
Headache, imbalance, and papilledema
NR
Posterior fossa
Mature teratoma
Total resection
Alive
9 months
Ferraz et al. (2014) [24]
NR
2 months
Down’s syndrome
NR
Posterior fossa
Mature teratoma
Incomplete resection
Recurrence
2 years
Thust et al. (2014) [14]
C-section, NR
11 weeks
Crying, irritability, and macrocephaly
NR
Posterior fossa
Teratoma
Incomplete resection
Recurrence
18 months
Fukuoka et al. (2014) [15]
SVD, 9 at 1 min, 10 at 5 min
12 days
Vomiting, head circumference enlargement
NR
Posterior fossa
Immature teratoma
Total resection
Alive
3 years
Algahtani et al. (2013) [4]
SVD, NR
5 years
Headache, vomiting, and irritability
NR
Posterior fossa
Mature teratoma
Total resection
Alive
1 year
Gao et al. (2013) [13]
NR, 9
4 months
Seizures, downward gaze palsy, binocular convergence
NR
Posterior fossa
Immature teratoma
Total resection
Alive
18 months
Rios et al. (2013) [25]
C section, NR
Prenatal
Incidental finding
5.3 × 4.8 cm
Posterior fossa
Immature teratoma
Biopsy
Dead
NA
Bakhtiar et al. (2012) [16]
SVD, NR
2 months
Lethargy and progressive head enlargement
5 cm
Posterior fossa
Immature teratoma
Total resection
Recurrence
4 years
Das et al. (2007) [26]
NR, NR
2 years
Headache vomiting, imbalance, and speech disturbance
NR
Posterior fossa
Immature teratoma
Incomplete resection
Dead
NA
Desai et al. (2001) [6]
C section, NR
10 days
Rapid head enlargement, vomiting, irritability
NR
Posterior fossa
Immature teratoma
Total resection
Dead
NA
Bavbek et al. (1999) [27]
SVD, NR
5 years
Head enlargement
NR
Posterior fossa
Mature teratoma
Total resection
Alive
NR
Hayashi et al. (1984) [28]
NR
27 days
NR
NR
Posterior fossa
Immature teratoma
Total resection
Dead
NA
SVD spontaneous vaginal delivery, NR not reported, C section caesarian section, NA not applicable
Furthermore, structural compression of the tectal plate by the tumor generates abnormal forces resulting in either brainstem ischemia or neuronal distortion before the development of hydrocephalus. Abnormal development of the tectal plate nuclei can be another cause of such syndrome in this patient population. This can be illustrated in our current case: partial improvement of Parinaud’s syndrome resulted after successful decompression, and no hemorrhage or infarction within the brainstem in the postoperative MRI scans suggests that tectal plate neurons may have been incompletely developed.
In a patient with congenital cerebellar teratoma, diagnosis may be prenatal or postnatal [17]. Prenatal diagnosis has increased compared to the past due to better prenatal follow-up and excellent radiological workups [17]. Diagnosis can be suspected on routine fetal ultrasound examination [17]. It may show intrauterine hydrocephalus, enlarged biparietal diameter, or brain tumor [17]. Antenatal diagnosis is usually possible as early as the 20th week of gestation [17, 18]. In addition to hydrocephalus, other common clinical conditions at the time of presentation are polyhydramnios, followed by respiratory distress and stillbirth [12]. If fetal ultrasound is suggestive of hydrocephalus due to a tumor, MRI of the fetus must be advised for definitive localization of the size and extent of the tumor and hydrocephalus [17, 18]. Usually, head circumference is enlarged before birth, and cephalopelvic disproportion becomes an indication for caesarian section [1719]. After delivery, parents may bring the baby in with a history of progressively increasing head circumference. Other history and examination are suggestive of hydrocephalus, which at this age is usually congenital [4, 15, 16]. Magnetic resonance imaging of the brain with and without gadolinium in such patients is diagnostic for tumor [4]. It usually shows a solid and cystic mass with heterogeneous enhancement and elements of calcification [4]. There is often hydrocephalus in posterior fossa teratomas as in our case report. Tumor markers like alpha-fetoprotein and β HCG help to suspect a malignant component in teratomas preoperatively [4].
Once the diagnosis of posterior fossa tumor is confirmed, the treatment of choice is complete excision of the lesion [4]. Afterward, complete clinical, as well as radiological, follow-up is recommended.
Poor survival of infants with congenital intracranial teratoma has been shown; a large number die prenatally and the rest shortly after birth [2]. In their literature review, Wakai and his colleagues found the 1-year survival rate of infants with congenital intracranial teratoma reaching 7.2% [5]. However, there have been some reports in which infants survived for a long time, such as our current case and that of Fukuoka et al. [15]. Long-term survival can be attributed to complete resection, yet this has not been entirely proven [20]. The location and the size of the teratoma are considered as significant prognostic factors rather than the histological grade [2]. Thus, posterior fossa teratomas are associated with poor outcome. Kitahara et al. have demonstrated that the use of neoadjuvant chemotherapy CARE can decrease tumor size and vascularity, paving the way for achieving total tumor resection and resulting in lower morbidity and mortality [21]. In their report, they unsuccessfully attempted surgical resection before initiation of neoadjuvant chemotherapy and then succeeded in achieving near-total resection after completing the CARE regimen [21]. This was unlike our current case, in which adjuvant chemotherapy was used after achieving total tumor resection. The unique aspect of our case is that it is the only one reporting a patient surviving more than 20 years after undergoing complete excision of a posterior fossa immature teratoma.

Conclusion

Congenital posterior fossa teratoma is a rare tumor that presents with significant large size and massive obstructive hydrocephalus. Early surgical resection is recommended with adequate perioperative care. Regular clinical and radiological follow-up is essential to assess the child’s neurological function and watch for early recurrence. Despite insufficient data in the literature about factors that favor a good outcome for posterior teratoma, we note that complete surgical resection is a significant prognosticator.

Acknowledgements

This research was not supported by any professional writing services or materials.

Funding

The design and collection, analysis, interpretation of data and writing of the manuscript has not been supported by any grant or fund.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.
This study was approved by the Research Ethics Committee of King Abdulaziz University Hospital.
All participants gave written consent for the publication of the identifying photographs.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Buetow PC, Smirniotopoulos JG, Done S. Congenital brain tumors: a review of 45 cases. AJNR Am J Neuroradiol. 1990;11(4):793–9.PubMed Buetow PC, Smirniotopoulos JG, Done S. Congenital brain tumors: a review of 45 cases. AJNR Am J Neuroradiol. 1990;11(4):793–9.PubMed
2.
Zurück zum Zitat Isaacs H Jr. Perinatal (fetal and neonatal) germ cell tumors. J Pediatr Surg. 2004;39(7):1003–13.CrossRef Isaacs H Jr. Perinatal (fetal and neonatal) germ cell tumors. J Pediatr Surg. 2004;39(7):1003–13.CrossRef
3.
Zurück zum Zitat Raisanen JM, Davis RL. Congenital brain tumors. Pathology. 1993;2(1):103–16.PubMed Raisanen JM, Davis RL. Congenital brain tumors. Pathology. 1993;2(1):103–16.PubMed
4.
Zurück zum Zitat Algahtani HA, Al-Rabia MW, Al-Maghrabi HQ, Kutub HY. Posterior fossa teratoma. Neurosciences. 2013;18(4):371–4.PubMed Algahtani HA, Al-Rabia MW, Al-Maghrabi HQ, Kutub HY. Posterior fossa teratoma. Neurosciences. 2013;18(4):371–4.PubMed
5.
Zurück zum Zitat Wakai S, Arai T, Nagai M. Congenital brain tumors. Surg Neurol. 1984;21:597–609.CrossRef Wakai S, Arai T, Nagai M. Congenital brain tumors. Surg Neurol. 1984;21:597–609.CrossRef
6.
Zurück zum Zitat Desai K, Nadkarni T, Muzumdar D, Goel A. Midline posterior fossa teratoma--case report. Neurol Med Chir. 2001;41(2):94–6.CrossRef Desai K, Nadkarni T, Muzumdar D, Goel A. Midline posterior fossa teratoma--case report. Neurol Med Chir. 2001;41(2):94–6.CrossRef
7.
Zurück zum Zitat Sardinas N, Marcos R, Pestana EM, Vargas J, Chi-Ramirez D, Rojas E, Esteban EM, Zarrabeitia L. Tumors of the posterior fossa in children. Rev Neurol. 1999;28(12):1153–8.PubMed Sardinas N, Marcos R, Pestana EM, Vargas J, Chi-Ramirez D, Rojas E, Esteban EM, Zarrabeitia L. Tumors of the posterior fossa in children. Rev Neurol. 1999;28(12):1153–8.PubMed
8.
Zurück zum Zitat Slavin KV, Ausman JI. Tumors of the pineal region. In: Rengachary SS, Wilkins RH, editors. Principles of neurosurgery. London: Mosby; 1994. p. 29.1–29.16. Slavin KV, Ausman JI. Tumors of the pineal region. In: Rengachary SS, Wilkins RH, editors. Principles of neurosurgery. London: Mosby; 1994. p. 29.1–29.16.
9.
Zurück zum Zitat Uken P, Sato Y, Smith W. MR findings of malignant intracranial teratomas in a neonate. Pediatr Radiol. 1986;16:504–5.CrossRef Uken P, Sato Y, Smith W. MR findings of malignant intracranial teratomas in a neonate. Pediatr Radiol. 1986;16:504–5.CrossRef
10.
Zurück zum Zitat Ventureyra EC. Pineal region: surgical management of tumors and malformations. Surg Neurol. 1981;16:77–84.CrossRef Ventureyra EC. Pineal region: surgical management of tumors and malformations. Surg Neurol. 1981;16:77–84.CrossRef
11.
Zurück zum Zitat Whittle IR, Simpson DA. Surgical management of neonatal intracranial teratoma. Surg Neurol. 1981;15:268–73.CrossRef Whittle IR, Simpson DA. Surgical management of neonatal intracranial teratoma. Surg Neurol. 1981;15:268–73.CrossRef
12.
Zurück zum Zitat Takaku A, Kodama N, Ohara H, Hori S. Brain tumor in newborn babies. Childs Brain. 1978;4(6):365–75.PubMed Takaku A, Kodama N, Ohara H, Hori S. Brain tumor in newborn babies. Childs Brain. 1978;4(6):365–75.PubMed
13.
Zurück zum Zitat Gao J, Zheng Z. Immature teratoma of the posterior cranial fossa in a 4-month-old infant: a case report. Oncol Lett. 2013;6(1):19–22.CrossRef Gao J, Zheng Z. Immature teratoma of the posterior cranial fossa in a 4-month-old infant: a case report. Oncol Lett. 2013;6(1):19–22.CrossRef
14.
Zurück zum Zitat Thust SC, Nandi D, Hann G. Acting on macrocephaly in the neonatal period: an illustrative case of congenital teratoma. BMJ Case Rep. 2014;2014. Thust SC, Nandi D, Hann G. Acting on macrocephaly in the neonatal period: an illustrative case of congenital teratoma. BMJ Case Rep. 2014;2014.
15.
Zurück zum Zitat Fukuoka K, Yanagisawa T, Suzuki T, Wakiya K, Matsutani M, Sasaki A, et al. Successful treatment of hemorrhagic congenital intracranial immature teratoma with neoadjuvant chemotherapy and surgery. J Neurosurg Pediatr. 2014;13(1):38–41.CrossRef Fukuoka K, Yanagisawa T, Suzuki T, Wakiya K, Matsutani M, Sasaki A, et al. Successful treatment of hemorrhagic congenital intracranial immature teratoma with neoadjuvant chemotherapy and surgery. J Neurosurg Pediatr. 2014;13(1):38–41.CrossRef
16.
Zurück zum Zitat Bakhtiar Y, Yonezawa H, Bohara M, Hanaya R, Okamoto Y, Sugiyama K, et al. Posterior fossa immature teratoma in an infant with trisomy 21: a case report and review of the literature. Surg Neurol Int. 2012;3:100.CrossRef Bakhtiar Y, Yonezawa H, Bohara M, Hanaya R, Okamoto Y, Sugiyama K, et al. Posterior fossa immature teratoma in an infant with trisomy 21: a case report and review of the literature. Surg Neurol Int. 2012;3:100.CrossRef
17.
Zurück zum Zitat Ferreira O. Prenatal diagnosis of intracranial tumors: a case report. Pediatr Neurosurg. 1993;19:84–8.CrossRef Ferreira O. Prenatal diagnosis of intracranial tumors: a case report. Pediatr Neurosurg. 1993;19:84–8.CrossRef
18.
Zurück zum Zitat Hoff NR, Mackay IM. Prenatal ultrasound diagnosis of intracranial teratoma. JCU. 1980;8:247–9.PubMed Hoff NR, Mackay IM. Prenatal ultrasound diagnosis of intracranial teratoma. JCU. 1980;8:247–9.PubMed
19.
Zurück zum Zitat Cavalheiro S, Moron AF, Hisaba W, Dastoli P, Silva NS. Fetal brain tumors. Childs Nerv Syst. 2003;19:529–36.CrossRef Cavalheiro S, Moron AF, Hisaba W, Dastoli P, Silva NS. Fetal brain tumors. Childs Nerv Syst. 2003;19:529–36.CrossRef
20.
Zurück zum Zitat Robles Fradejas M, Gonzalo Garcia I, De Las Casas Quispe AC, Martin Garcia A, Garcia Higuera MI, Rodriguez Minguelez M, et al. Fetal intracranial immature teratoma: presentation of a case and a systematic review of the literature. J Matern Fetal Neonatal Med. 2017;30(10):1139–46.CrossRef Robles Fradejas M, Gonzalo Garcia I, De Las Casas Quispe AC, Martin Garcia A, Garcia Higuera MI, Rodriguez Minguelez M, et al. Fetal intracranial immature teratoma: presentation of a case and a systematic review of the literature. J Matern Fetal Neonatal Med. 2017;30(10):1139–46.CrossRef
21.
Zurück zum Zitat Kitahara T, Tsuji Y, Shirase T, Yukawa H, Takeichi Y, Yamazoe N. Neoadjuvant chemotherapy for facilitating surgical resection of infantile massive intracranial immature teratoma. Tohoku J Exp Med. 2016;238(4):273–8.CrossRef Kitahara T, Tsuji Y, Shirase T, Yukawa H, Takeichi Y, Yamazoe N. Neoadjuvant chemotherapy for facilitating surgical resection of infantile massive intracranial immature teratoma. Tohoku J Exp Med. 2016;238(4):273–8.CrossRef
22.
Zurück zum Zitat Algahtani H, Shirah B, Abdullah A, Bazaid A. Teratoma of the nervous system: a case series. Neurocirugia (Astur). 2018;29(3):143–9.CrossRef Algahtani H, Shirah B, Abdullah A, Bazaid A. Teratoma of the nervous system: a case series. Neurocirugia (Astur). 2018;29(3):143–9.CrossRef
23.
Zurück zum Zitat Daugherty C, Ngo T, Drehner D, Maugans T. Mature teratoma confined to the posterior fossa. Pediatr Neurosurg. 2016;51(2):93–8.CrossRef Daugherty C, Ngo T, Drehner D, Maugans T. Mature teratoma confined to the posterior fossa. Pediatr Neurosurg. 2016;51(2):93–8.CrossRef
24.
Zurück zum Zitat Ferraz ST, Valera ET, Brassesco MS, Santos de Oliveira R, Carlos dos Santos A, Saggioro FP, et al. Intracranial teratoma in children: the role of chromosome 21 trisomy. Neuropathology. 2014;34(2):197–200.CrossRef Ferraz ST, Valera ET, Brassesco MS, Santos de Oliveira R, Carlos dos Santos A, Saggioro FP, et al. Intracranial teratoma in children: the role of chromosome 21 trisomy. Neuropathology. 2014;34(2):197–200.CrossRef
25.
Zurück zum Zitat Rios LT, Araujo Junior E, Nacaratto DC, Nardozza LM, Moron AF, da Gloria Martins M. Prenatal diagnosis of intracranial immature teratoma in the third trimester using 2D and 3D sonography. J Med Ultrason. 2013;40(1):57–60.CrossRef Rios LT, Araujo Junior E, Nacaratto DC, Nardozza LM, Moron AF, da Gloria Martins M. Prenatal diagnosis of intracranial immature teratoma in the third trimester using 2D and 3D sonography. J Med Ultrason. 2013;40(1):57–60.CrossRef
26.
Zurück zum Zitat Das S, Muro K, Goldman S, Rajaram V, DiPatri AJ Jr. Medulloblastoma arising from an immature teratoma of the posterior fossa. Case Rep J Neurosurg. 2007;106(1 Suppl):61–4. Das S, Muro K, Goldman S, Rajaram V, DiPatri AJ Jr. Medulloblastoma arising from an immature teratoma of the posterior fossa. Case Rep J Neurosurg. 2007;106(1 Suppl):61–4.
27.
Zurück zum Zitat Bavbek M, Altinors N, Caner H, Agildere M, Cinemre O, Guz T, et al. Giant posterior fossa teratoma. Childs Nerv Syst. 1999;15(6–7):359–61.CrossRef Bavbek M, Altinors N, Caner H, Agildere M, Cinemre O, Guz T, et al. Giant posterior fossa teratoma. Childs Nerv Syst. 1999;15(6–7):359–61.CrossRef
28.
Zurück zum Zitat Hayashi T, Hashimoto T, Harada K, Okamoto Y, Shojima K, Honda E. A huge teratoma in the posterior fossa in a neonate. Kurume Med J. 1984;31(4):335–7.CrossRef Hayashi T, Hashimoto T, Harada K, Okamoto Y, Shojima K, Honda E. A huge teratoma in the posterior fossa in a neonate. Kurume Med J. 1984;31(4):335–7.CrossRef
Metadaten
Titel
Infratentorial immature teratoma of congenital origin can be associated with a 20-year survival outcome: a case report and review of literature
verfasst von
Yazid Maghrabi
Maher E. Kurdi
Saleh S. Baeesa
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2019
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-019-1564-1

Weitere Artikel der Ausgabe 1/2019

World Journal of Surgical Oncology 1/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.